MR Radiomic Features in Prostate Cancer

NCT04219059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-01-26

No results posted yet for this study

Summary

A combination of correct interpretation of imaging and biopsy has given promising results in terms of detecting clinically significant cancer at radical prostatectomy.

Conditions

Sponsors & Collaborators

  • IBFM-CNR (Istituto di Bioimmagini e Fisiologia Molecolare, National Research Council, Segrate, Italy

    collaborator UNKNOWN
  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-03
Primary Completion
2021-03-30
Completion
2021-03-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04219059 on ClinicalTrials.gov